Nosebleed lip pack
AssigneeRemedease, Inc.
InventorAmy Diane Rix
Life of this patent
Estimating the term…
Abstract
A device for treatment of nosebleeds having an elongated body configured to be positioned between the upper gum and the portion of the face below the nose and above the top lip of a human. When so positioned intra-orally, the device exerts pressure on an area of nasal vascularization of the human. Also, a nosebleed package having a sterile inside environment and a nosebleed device packaged therein, and a box containing a plurality of nosebleed packages.
Claims24
A device for treatment of nosebleeds comprising an elongated body configured to be positioned between the upper gum and a portion of the face below the nose and above the top lip of a human so as to exert pressure on an area of nasal vascularization of the human, the device further including compression padding longitudinally disposed on a portion of the elongated body to apply pressure to an area of nasal vascularization when inserted intra-orally, and wherein the elongated body has a first end and a second end, each end having a linear, terminal edge, wherein the linear, terminal edge is positioned perpendicular to a longitudinal axis of the elongated body, wherein at least one of the first and second ends is tapered to the portion of the elongated body upon which the compression padding is disposed and further wherein the elongated body has a cross-section having a shape selected from the group consisting of a circle, a triangle, a square, a rhomboid, a parallelepiped, a pentagon, and a hexagon.
A device for the treatment of nosebleeds comprising an elongated body from about 30 mm to about 80 mm in length and from about 4 mm to about 12 mm in diameter, wherein the body has a cross-section having a shape selected from the group consisting of a circle, an oval, a triangle, a square, a rhomboid, a parallelepiped, a pentagon, and a hexagon, further wherein the body comprises a liquid-absorbent material having disposed longitudinally over a portion thereof compression padding, wherein the padding has a thickness from about 1 mm to about 4 mm thick and a length from about a quarter to about two-thirds of the length of the device, and wherein the elongated body has a first end and a second end, each end having a linear, terminal edge, wherein the linear, terminal edge is positioned perpendicular to a longitudinal axis of the elongated body, wherein at least one of the first and second ends is tapered to the portion of the elongated body upon which the compression padding is disposed, so that the device is configured to be positioned between the upper gum and a portion of the face below the nose and above the top lip of a human, with the padding directed upwards toward the nose so as to exert pressure on an area of nasal vascularization of the human.
A nosebleed package comprising in combination a container having a sterile inside environment and a device for treating nosebleeds, the device being disposed inside the container and being an elongated body having a cross-section of a shape selected from the group consisting of a circle, an oval, a triangle, a square, a rhomboid, a parallelepiped, a pentagon, and a hexagon, configured to be positioned between the upper gum and a portion of the face below the nose and above the top lip of a human so as to exert pressure on an area of nasal vascularization of the human, wherein the device further comprises compression padding longitudinally disposed on a portion of the elongated body, and wherein the elongated body has a first end and a second end, each end having a linear, terminal edge, wherein the linear, terminal edge is positioned perpendicular to a longitudinal axis of the elongated body, wherein at least one of the first and second ends is tapered to the portion of the elongated body upon which the compression padding is disposed.
A nosebleed package comprising in combination a container having a sterile inside environment and a sterile device for treating nosebleeds, the device being disposed inside the container, wherein the container comprises blister packaging and the device comprises an elongated body from about 30 mm to about 80 mm in length and from about 4 mm to about 12 mm in diameter, wherein the body comprises a liquid-absorbent material and the device further comprises compression padding longitudinally disposed on a portion of the elongated body, wherein the padding has a thickness from about 1 mm to about 4 mm thick and a length from about a quarter to about two-thirds of the length of the device, and wherein the elongated body has a first end and a second end, each end having a linear, terminal edge, wherein the linear, terminal edge is positioned perpendicular to a longitudinal axis of the elongated body, wherein at least one of the first and second ends is tapered to the portion of the elongated body upon which the compression padding is disposed, so that the device is configured to be positioned between the upper gum and a portion of the face below the nose and above the top lip of a human, with the padding directed upwards toward the nose so as to exert pressure on an area of nasal vascularization of the human.
A box containing a multiplicity of nosebleed packages comprising individually packaged nosebleed devices, wherein each nosebleed package comprises a nosebleed device in combination with and disposed inside a container having a sterile inside environment, and wherein each nosebleed device comprises an elongated body configured to be positioned between the upper gum and a portion of the face below the nose and above the top lip of a human so as to exert pressure on an area of nasal vascularization of the human, wherein the device further comprises compression padding longitudinally disposed over a portion of the elongated body, and wherein the elongated body has a first end and a second end, each end having a linear, terminal edge, wherein the linear, terminal edge is positioned perpendicular to a longitudinal axis of the elongated body, and at least one of the first and second ends is tapered to the portion of the elongated body upon which the compression padding is disposed.
A box containing a multiplicity of nosebleed packages comprising individually packaged nosebleed devices, wherein each nosebleed package comprises a nosebleed device in combination with and disposed inside a container having a sterile inside environment, and wherein each container comprises blister packaging and each device comprises an elongated body from about 30 mm to about 80 mm in length and from about 4 mm to about 12 mm in diameter, wherein the body comprises a liquid-absorbent material, wherein each device further comprises compression padding longitudinally disposed on a portion of the elongated body, wherein the padding has a thickness from about 1 mm to about 4 mm thick and a length from about a quarter to about two-thirds of the length of the device, and wherein the elongated body has a first end and a second end, each end having a linear, terminal edge, wherein the linear, terminal edge is positioned perpendicular to a longitudinal axis of the elongated body, wherein at least one of the first and second ends is tapered to the portion of the elongated body upon which the compression padding is disposed, so that the elongated body is configured to be positioned between the upper gum and a portion of the face below the nose and above the top lip of a human so as to exert pressure on an area of nasal vascularization of the human, and wherein a first plurality of the nosebleed packages contains nosebleed devices of a first size and a second plurality of the nosebleed packages contains devices of a second size.
Dependencies are inferred from the claim text.